SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

39.57

35925.94

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.69

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	3790.20	3723.49	3407.25	3216.34	3217.51	2920.48
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	3790.20	3723.49	3407.25	3216.34	3217.51	2920.48
Other Income	145.20	147.26	143.17	114.96	1423.27	217.71
Stock Adjustments	-13.50	-51.23	69.64	-67.25	-13.83	26.12
Total Income	3921.90	3819.52	3620.06	3264.05	4626.95	3164.31
EXPENDITURE :
Raw Materials	1310.52	1315.97	1358.07	1182.78	1281.91	1275.49
Power & Fuel Cost	30.36	30.18	29.64	29.60	27.83	26.08
Employee Cost	607.25	579.70	624.39	594.99	610.23	616.16
Other Manufacturing Expenses	101.49	114.26	113.61	99.05	120.14	110.59
Selling & Administrative Expenses	366.21	383.95	374.71	370.30	343.57	242.00
Miscellaneous Expenses	60.68	78.91	239.12	84.32	85.69	287.75
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	2476.51	2502.98	2739.54	2361.04	2469.38	2558.07
Operating Profit	1445.40	1316.54	880.52	903.01	2157.57	606.24
Interest	2.73	1.31	1.80	1.81	1.99	3.53
Gross Profit	1442.67	1315.23	878.72	901.20	2155.58	602.71
Depreciation	66.44	66.79	69.68	65.77	68.19	78.60
Profit Before Tax	1376.23	1248.44	809.04	835.43	2087.39	524.11
Tax	354.95	323.18	235.71	246.05	407.36	158.67
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	9.46	6.20	-11.36	-18.37	-10.49	7.87
Reported Net Profit	1011.82	919.05	584.69	607.75	1690.53	357.57
Extraordinary Items	104.00	92.04	-66.58	21.05	11.18	-117.79
Adjusted Net Profit	907.82	827.01	651.27	586.70	1679.35	475.36
Adjustment below Net Profit	0.00	0.00	0.00	-17.08	-11.05	0.00
P & L Balance brought forward	1044.37	870.71	828.12	1745.02	562.71	882.77
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	711.51	745.39	542.10	1524.66	508.22	677.62
P & L Balance carried down	1344.68	1044.37	870.71	811.03	1733.98	562.71
Dividend	0.00	203.29	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	570.00	540.00	320.00	320.00	900.00	300.00
Dividend Per Share(Rs)	57.00	54.00	32.00	32.00	90.00	30.00
Earnings Per Share-Unit Curr	59.73	54.25	34.51	35.88	99.79	21.11
Earnings Per Share(Adj)-Unit Curr	59.73	54.25	34.51	35.88	99.79	21.11
Book Value-Unit Curr	132.30	115.06	105.31	103.48	158.06	88.37
Book Value(Adj)-Unit Curr	132.30	115.06	105.31	103.48	158.06	88.37

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)